Chico, A, Aguilera-Hurtado, E, Albareda, M, Moreno-Fernández, J, Beato-Vibora, P, Fernández-Rubio, E, Cuesta, M, Bartual, A, Ampudia-Blasco, FJ, Bandrés, O, Ares, J, Rivero, MT, Picón-César, MJ. A multicenter prospective evaluation of the benefits of Dexcom ONE plus in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study. ACTA DIABETOLOGICA. 2026; 63(6)DOI:10.1007/s00592-026-02682-9. PMID:41964691. IF:2.900(Q3/6D).

Lazarus, JV, White, TM, Agirre-Garrido, L, Abeysekera, KWM, Brennan, PN, Bruha, R, Buttigieg, S, Carrieri, P, Cortez-Pinto, H, Flisiak, R, Francque, SMA, Frühbeck, G, Gheorghe, LS, Hagström, H, Holleboom, AG, Ivanov, K, Jensterle, M, Jepsen, P, Kupcinskas, J, Mark, HE, Mauricio, D, Bibi, SM, Moreno, C, Mrzljak, A, Papanicolaou, E, Papp, M, Papatheodoridis, G, Peck-Radosavljevic, M, Pugliese, N, Ryan, JD, Ribeiro, RT, Salupere, R, Skladany, L, Tolmane, I, Yki-Järvinen, H, Schattenberg, JM, Pericàs, JM. Assessing Europe's policy readiness to confront the MASLD/MASH public health threat. Lancet Regional Health-Europe. 2026; 65DOI:10.1016/j.lanepe.2026.101713. PMID:42266904. IF:13.000(Q1/1D).

Martinez-Mores, S, Fillat, MBV, Vlacho, B, Navas, E, Fernandez-Camins, B, Franch-Nadal, J, Mauricio, D. Prevalence and clinical characteristics of erectile dysfunction among men with type 2 diabetes in primary care: A cross-sectional study in Catalonia. Primary Care Diabetes. 2026; 20(3)DOI:10.1016/j.pcd.2026.04.006. PMID:42000296. IF:2.300(Q2/5D).

Ramon-Granés, M, Fernàndez-Camins, B, Lapena-Estella, C, Orfila-Pernas, F, de la Puente, JB, Vlacho, B, Mauricio, D, Navas-Méndez, E, Franch-Nadal, J. Clinical trends in Catalonia's Primary Care Setting (2018-2023) in Elderly (=75 years) and Frail Adults with Type 2 Diabetes. Primary Care Diabetes. 2026; 20(3)DOI:10.1016/j.pcd.2026.03.010. PMID:41916804. IF:2.300(Q2/5D).

Biagetti, B, Cardona-Arias, A, Soto-Moreno, A, García, MDO, Rodríguez, MDM, Gonzalez-Fernandez, L, Castro, A, Guerrero-Pérez, F, Iglesias, P, Camara, R, Paja, M, Lázaro, VA, Simo-Servat, A, Lozano-Aida, C, Echarri, AI, Valero, LM, Villar-Taibo, R, Bernabéu, I, Fajardo-Montañana, C, Aulinas, A, García-Centeno, R, Hanzu, F, Araujo-Castro, M. Glucocorticoid-Induced Positive Feedback in Cushing Disease: Insights From a Spanish Multicenter Cohort. Endocrine Practice. 2026; 32(6)DOI:10.1016/j.eprac.2025.12.013. PMID:41443540. IF:4.600(Q1/3D).

Biswas, S, Aggarwal, A, Lo, GH, Luo, XF, Yang, L, Escorsell, A, Mehta, S, Swaroop, S, Agarwal, S, Agarwal, A, Saxena, S, Mishra, AK, Tripathi, S, Gunjan, D, Gamanagatti, S, Shalimar. Endovascular Interventions Reduce Rebleeding in Patients With Gastric Varices: An Individual Patient Data Meta-Analysis. Clinical Gastroenterology and Hepatology. 2026; 24(6)DOI:10.1016/j.cgh.2026.01.002. PMID:41539349. IF:12.000(Q1/1D).

Narváez, J, Sirvent, E, Sánchez-Rodríguez, I, Sabaté-Llobera, A, Cortés-Romera, M, Moya-Alvarado, P, Rozadilla, A, Reina, D. Prevalence and characteristics of subclinical polymyalgia rheumatica in patients with giant cell arteritis. RHEUMATOLOGY. 2026; 65(6)DOI:10.1093/rheumatology/keag285. PMID:42226006. IF:4.400(Q1/1D).

Salcedo-Allende, MT, Chimisana, VF, Llanos, ACZ, Piñol, TS, Freixas, MC, Sanz, IA, Ortiz, MR, Munoz, CM, Olivar, AA, Martos, RL, Gallego, AH, Hijos, MG, Fernández, MLD, Coma, MI, Muñoz, CG, Leal, CJB, Fumagalli, C, Szafranska, J, Borrego, MV, Cabús, SS, Piñas, JCF, Raya, ECV. Position statement on the pathological assessment of pancreatic resection specimens in pancreatic ductal adenocarcinoma by the Societat Catalana de Pàncrees and the Societat Catalana d'Anatomia Patologica. Gastroenterologia y Hepatologia. 2026; 49(6)DOI:10.1016/j.gastrohep.2026.502700. PMID:41655901. IF:1.900(Q3/7D).

Dossa, F, Callegaro, D, Palmerini, E, Quagliuolo, V, Martin-Broto, J, Grignani, G, Brunello, A, Blay, JY, Beveridge, RD, Ferraresi, V, Lugowska, IA, Pizzamiglio, S, Verderio, P, Palassini, E, Bianchi, G, Stacchiotti, S, Bague, S, Coindre, JM, Dei Tos, AP, Gronchi, A. Who really benefits from chemotherapy in high-risk localized soft tissue sarcoma? A virtual twin analysis of ISG-STS 1001. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.11573. PMID:. IF:41.900(Q1/1D).

Costa-Comellas, L, Monforte, M, Sanchez-Montañez, A, Romero-Duque, P, Pegoraro, E, Díaz-Manera, J, Vlodavets, D, Maggi, L, Moscatelli, M, DAmico, A, Olivé, M, Alonso-Pérez, J, Comi, G, Escudero-Fernández, JM, Urcuyo, GS, Pichiecchio, A, Berardinelli, A, Claeys, KG, Bruno, C, Panicucci, C, Bortolani, S, Torchia, E, Ricci, E, Monges, S, Bevilacqua, JA, Diaz-Jara, J, Walter, MC, Thiele, S, Lokken, N, Vissing, J, Quijano-Roy, S, Carlier, RY, Voermans, NC, Marini-Bettolo, C, Guglieri, M, Straub, V, Leonardis, L, Munell, F, Gómez-Andrés, D, Tasca, G. Whole-Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies. Annals of Clinical and Translational Neurology. 2026; 13(6)DOI:10.1002/acn3.70303. PMID:41475892. IF:3.900(Q1/3D).

Stampacchia, S, Bernasconi, F, Van De Ville, D, Amico, E, Kohoutová, L, Taylor, JP, Thomas, A, Pagonabarraga, J, Kulisevsky, J, Blanke, O. Patient-specific functional networks track early cognitive alterations and minor hallucinations in Parkinson's disease. Nature Mental Health. 2026; 4(6)DOI:10.1038/s44220-026-00657-x. PMID:. IF:(Q/D).

Valls-Carbó, A, Millán, M, Castaño, C, De La Ossa, NP, Cardona, P, Flores, A, Biarnes, C, Boix, M, Urra, X, Terceño, M, Olivé-Gadea, M, Renom, PC, Rodríguez-Campello, A, Purroy, FF, Yugueros, B, Cánovas, D, Caamaño, IR, Beltrán-Mármol, B, Remollo, S, De Dios, M, Bashir, S, Aja, L, Gramegna, LL, Pastrana, M, Hernández-Pérez, M. Simple against advanced imaging for the selection of stroke therapy in the extended window (VESTA study). European Stroke Journal. 2026; 11(6)DOI:10.1093/esj/aakag068. PMID:42308555. IF:4.500(Q1/2D).

Cubala, WJ, Bajbouj, M, Bauer, M, Baune, BT, Cardoner, N, Devlin, F, Doolin, K, Herrero, RMD, Elices, M, Feeney, A, Galuszko-Wegielnik, M, Jakuszkowiak-Wojten, K, Janu, L, Kelly, JR, Ledden, K, Maclsaac, R, Madero, S, Mcinerney, SJ, Montejo, AL, Nawka, A, Pálenícek, T, Solà, VP, Ramaekers, JG, Reif, A, Ritter, P, Ryan, F, Svendsen, CB, Sweeney, C, Terwey, TH, Trivedi, MH, Valcheva, V, Vieta, E, Thase, ME. GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2026; 83(6)DOI:10.1001/jamapsychiatry.2026.0096. PMID:41879760. IF:17.100(Q1/1D).

Esquirol, A, Pascual, MJ, Montoro, J, Piñana, JL, Ferrà, C, Herruzo, B, Garcia-Cadenas, I, Balaguer, A, Perez, A, Huguet, M, Redondo, S, Villalba, M, Hernandez-Boluda, JC, Chorao, P, Hernani, R, Sanz, J, Solano, C, Sierra, J, Martino, R. Comparison of three strategies of GvHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs calcineurin inhibitors-MMF vs sirolimus-MMF (vol 30, pg 1025, 2024). Transplantation And Cellular Therapy. 2026; 32(6)DOI:10.1016/j.jtct.2025.06.011. PMID:40516920. IF:4.400(Q1/1D).

Fox, ML, Martínez, AP, Esquirol, A, Navarro, V, Cabirta, A, García-Cadenas, I, Almorox, RB, Fonseca-Santos, M, Fernando, IH, Bento, L, Raya, MP, Montoro, J, Calbacho, M, Ripa, TZ, Coll, CFI, Morales, RH, Ortí, G, Martino, R, González, PFC, López-Corral, L, Pérez-López, E, Navarro-Fernandez, J, Cascón, MJP, Sola, M, Catarineu, AT, Salamero, O, González, AP, Solano, C, Kwon, M, Valcárcel, D. Haploidentical Donor versus Mismatched Unrelated Donor in Reduced-Intensity Conditioning Stem Cell Transplantation: A GETH-TC. Transplantation And Cellular Therapy. 2026; 32(6)DOI:10.1016/j.jtct.2026.01.013. PMID:41534839. IF:4.400(Q1/1D).

Esquirol, A, Pascual, MJ, Garcia-Cadenas, I, Herruzo, B, Ferra, C, Torio, A, Torrent, A, Cuesta, M, Martino, R, Sierra, J. Combining three different pre-transplant scores improves predictive value in patients after haploidentical stem cell transplantation with TBF conditioning and PTCy (vol 27 , pg 614.e1 , 2021 ). Transplantation And Cellular Therapy. 2026; 32(6)DOI:10.1016/j.jtct.2025.06.010. PMID:40623446. IF:4.400(Q1/1D).

Powles, T, van der Heijden, MS, Bedke, J, Valderrama, BP, Kikuchi, E, Galsky, MD, Loriot, Y, Iyer, G, Yu, EY, Hoffman-Censits, J, Mar, N, Vulsteke, C, Sridhar, SS, Maroto-Rey, JP, Park, SH, Moreno, BH, Lichfield, J, Yu, XS, Wirtz, H, Gupta, S. Enfortumab vedotin plus pembrolizumab (EV plus P) vs chemotherapy for previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): 3.5-year follow-up and response analyses from the phase 3 EV-302 study.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.4507. PMID:. IF:41.900(Q1/1D).

Portu, M, Sanz-Beltran, J, Pellicer, A, Navarro, B, Monleon, AR, Capdevila, P, Tallafigo, FL, Moran, T, Catot, S, Munoz, SP, Arriola, E, Sanchez, A, Osorio, K, Muñoz, A, Isla, D, Guarner, B, Piedra, A, Recio, SM, Barba, A, Majem, M. Prognostic factors and impact of concomitant medication in extensive-stage small cell lung cancer (ES-SCLC) treated with first-line chemotherapy plus anti-PD-L1: A Spanish multicenter real-world study.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.8107. PMID:. IF:41.900(Q1/1D).

Forster, MD, Forget, F, Murillo, SM, García-Fructuoso, I, Ibrahim, NK, Marathe, O, Kristensen, CA, Laban, S, Metcalf, R, Majem, M, Peguero, JA, Wildiers, H, Marmé, F, Brana, I, Mueller, C, Brignone, C, Triebel, F. Impact of eftilagimod alfa, an APC activator via MHC class II, on lymphocyte activation and survival outcomes in metastatic cancer patients.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.2569. PMID:. IF:41.900(Q1/1D).

Crous, C, de Herreros, MG, Torras, OR, Jimenez, N, Ferrer-Mileo, L, Garcia-Esteve, S, Rodriguez, L, Altamirano, M, Salinas, B, Cobo-Lopez, S, Fernandez-Mañas, L, Duran, MAC, Pous, AF, Chirivella, I, Figols, M, Costa, SC, Rodriguez-Vida, A, Anguera, G, González, NS, Mellado, B. Clinical impact and molecular profiling of PTEN loss and TMPRSS2:ERG fusion in metastatic hormone-sensitive prostate cancer.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.5101. PMID:. IF:41.900(Q1/1D).